Wellness Molecular
Organisms, resistance determinants, coverage, polymicrobial planning, dosing, interactions and warnings, on one report the prescriber can act on.
Incomplete data is confirmed with you, never guessed. An organism, gene or allergy the engine does not recognize, or dates that disagree, come straight back for correction. No report is produced on a guess.
The report names what the assay cannot distinguish. Where a plan depends on susceptibility the panel cannot measure, it says so, and it writes down the step-down to take once culture returns.
What it does
A case from our sample reports: an 84-year-old man, urine, Klebsiella pneumoniae with an ESBL gene detected, and a documented penicillin allergy.
What a result report gives you
Klebsiella pneumoniae
Extended-spectrum beta-lactamase
Allergy on file: penicillin
Accurate, and it leaves every decision open:
What the engine gives you
Ertapenem
1 g IV/IM once daily · 7 days if clinically improving
Resistance, read for what it does
Some resistance comes from losing a function, some from gaining one, and some genes defeat only part of a drug. The engine reads every gene for what it actually does.
Nitrofurantoin is switched on by the bacterium's own enzymes. Resistance comes from losing them, so finding the gene is not resistance, and a first-line bladder agent stays available.
In the sample report: nfsA detected, nitrofurantoin retained.
Isoniazid and pyrazinamide are also switched on by the organism. A mutation that disables one of those enzymes takes out that drug alone, not the rest of the tuberculosis regimen.
Organisms such as Enterobacter carry a built-in enzyme that can ramp up once therapy starts. The report ranks down the drugs it defeats, even when the panel detects no gene at all.
A sulfonamide-resistance gene compromises one half of trimethoprim-sulfamethoxazole. The report says which half, and what that does and does not rule out.
In the sample report: sul1 detected, TMP-SMX kept as the cystitis option.
A blank is not a green light. When the marker that matters for a recommended drug was not detected, the report says so, rather than letting silence read as susceptible.
Stewardship
A stewardship tool that only ever recommends drugs is not a stewardship tool.
Norovirus on a stool panel returns a supportive-care plan, with rehydration, diet, antiemetics and escalation signs, and states plainly that antibiotics are not indicated.
Open the norovirus reportWhere no antimicrobial option exists, a rhinovirus, say, the report says so, and that this is not a reason to broaden therapy.
Maintenance
Antimicrobial guidance moves every year. A report built on a superseded guideline still looks completely normal.
Every recommendation traces to a named U.S. source. When a body archives a guideline, the rule is re-anchored or retired, never left standing because it still reads plausibly.
Before a new engine version reaches your reports, your laboratory administrators get a notice in the portal and by e-mail saying what changes and when.
Every change is recorded down to the rule and the source behind it, and we can show you that record.
Comparison
Measured against a plain result report, and against interpretive reporting generally.
| Aspect | Basic result report | Interpretive reporting, generally | Wellness Reporting Suite |
|---|---|---|---|
| What arrives | Organisms and genes detected | A suggested drug, sometimes a dose | Ranked plan with dose, route, duration and alternatives |
| Resistance | Gene listed | Usually narrative | What the gene rules out, which agents remain, coverage per organism |
| Basis for each recommendation | None | Rarely disclosed per rule | Hundreds of decision rules, each traced to published U.S. guidance and research |
| AI at report time | Not applicable | Often not disclosed either way | None: every recommendation comes from fixed rules, never from an AI model |
| Safety screening | None | Varies | Allergy, boxed warnings, label interactions, age, pregnancy, organ function |
| Incomplete data | Reported as-is | Varies | Confirmed with you before we interpret it |
| Before it reaches you | Lab result review | Typically none | Screened on the finished report; anything flagged is held until resolved |
| Charge on a correction | Not applicable | Often re-billed | Never. One accession is billed once, ever |
| Charge on a negative | Usually billed | Usually billed | No charge for a true negative |
The middle column describes the category in general, not any named provider.
Switching
The report arrives where your results already arrive. Nothing changes about how your staff orders or collects.
No change to requisitions, specimen handling or collection kits. The engine reads the panel result; it does not change the panel.
Delivered into the same record alongside the result, as a PDF your staff already knows how to open.
Prefer reports straight into your own system? We publish a documented, secure integration and an onboarding guide for your IT team.
Delivery setup, mapping and onboarding are on us. Your staff keeps working exactly the way it does today.